Ever/Body, a cosmetic dermatology provider of personalized, tech-enabled services, raised $38M in Series B funding, consisting of both venture equity and debt.
The round, which brought total capital raised to date to $52m, was led by Tiger Global Management, with participation from Addition, Fifth Wall, MetaProp, and Gaingels, and existing investors Declaration Partners, ACME Capital and Redesign Health.
The company intends to use the funds for:
- market expansion, with the planned opening of multiple new brick and mortar locations,
- roll out of a line of branded prescription dermatology products,
- enhancement of proprietary technology and client experience, and
- investment in new services to expand its current treatment menu.
Founded in 2019 by Amy Shecter, CEO, Ever/Body is a cosmetic dermatology company with a personalized, tech-driven experience from online booking, medical records and progress tracking, to advanced treatments. The company offers a curated menu of medically-tested procedures, vetted and administered by experienced medical professionals and tailored to each patient’s unique features and skincare goals.
The company was founded by Kate Twist, who leads its Board of Directors as Board Chair, and Karen Castelletti, who serves as Chief Technology Officer.
Ever/Body currently has two locations in New York City’s SoHo and Flatiron neighborhoods.